258 related articles for article (PubMed ID: 30969479)
1. The GLP-1 receptor agonist liraglutide protects against oxidized LDL-induced endothelial inflammation and dysfunction via KLF2.
Yue W; Li Y; Ou D; Yang Q
IUBMB Life; 2019 Sep; 71(9):1347-1354. PubMed ID: 30969479
[TBL] [Abstract][Full Text] [Related]
2. Glucagon-like peptide-1 receptor agonist dulaglutide prevents ox-LDL-induced adhesion of monocytes to human endothelial cells: An implication in the treatment of atherosclerosis.
Chang W; Zhu F; Zheng H; Zhou Z; Miao P; Zhao L; Mao Z
Mol Immunol; 2019 Dec; 116():73-79. PubMed ID: 31630078
[TBL] [Abstract][Full Text] [Related]
3. Montelukast inhibits oxidized low-density lipoproteins (ox-LDL) induced vascular endothelial attachment: An implication for the treatment of atherosclerosis.
Di X; Tang X; Di X
Biochem Biophys Res Commun; 2017 Apr; 486(1):58-62. PubMed ID: 28246014
[TBL] [Abstract][Full Text] [Related]
4. The neurokinin-1 receptor antagonist aprepitant ameliorates oxidized LDL-induced endothelial dysfunction via KLF2.
Zheng J; Chen K; Zhu Y; Wang H; Chen Z; Yong X; Yin H; Chen J; Lai K; Liu Y
Mol Immunol; 2019 Feb; 106():29-35. PubMed ID: 30576949
[TBL] [Abstract][Full Text] [Related]
5. Liraglutide ameliorates oxidized LDL-induced endothelial dysfunction by GLP-1R-dependent downregulation of LOX-1-mediated oxidative stress and inflammation.
Ying W; Meiyan S; Wen C; Kaizu X; Meifang W; Liming L
Redox Rep; 2023 Dec; 28(1):2218684. PubMed ID: 37278349
[TBL] [Abstract][Full Text] [Related]
6. Azilsartan ameliorates ox-LDL-induced endothelial dysfunction via promoting the expression of KLF2.
Li W; Wang C; Zhang D; Zeng K; Xiao S; Chen F; Luo J
Aging (Albany NY); 2021 May; 13(9):12996-13005. PubMed ID: 33946046
[TBL] [Abstract][Full Text] [Related]
7. CD4+CD25+Foxp3+ regulatory T cells protect endothelial function impaired by oxidized low density lipoprotein via the KLF-2 transcription factor.
Li M; Wang X; Fu W; He S; Li D; Ke Q
Cell Physiol Biochem; 2011; 28(4):639-48. PubMed ID: 22178876
[TBL] [Abstract][Full Text] [Related]
8. The DPP-4 inhibitor saxagliptin ameliorates ox-LDL-induced endothelial dysfunction by regulating AP-1 and NF-κB.
Ma S; Bai Z; Wu H; Wang W
Eur J Pharmacol; 2019 May; 851():186-193. PubMed ID: 30639312
[TBL] [Abstract][Full Text] [Related]
9. Humanin prevents high glucose-induced monocyte adhesion to endothelial cells by targeting KLF2.
Wang X; Wu Z; He Y; Zhang H; Tian L; Zheng C; Shang T; Zhu Q; Li D; He Y
Mol Immunol; 2018 Sep; 101():245-250. PubMed ID: 30029058
[TBL] [Abstract][Full Text] [Related]
10. The antagonist of P2Y11 receptor NF157 ameliorates oxidized LDL-induced vascular endothelial inflammation.
Kuang Y; Liu H; Guo S; Wang Y; Zhang H; Qiao Y
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):1839-1845. PubMed ID: 31066305
[TBL] [Abstract][Full Text] [Related]
11. Lunasin abrogates monocytes to endothelial cells.
Zhu Y; Li H; Wang X
Mol Immunol; 2017 Dec; 92():146-150. PubMed ID: 29096169
[TBL] [Abstract][Full Text] [Related]
12. Fractionated radiation suppresses Kruppel-like factor 2 pathway to a greater extent than by single exposure to the same total dose.
Sadhukhan R; Leung JWC; Garg S; Krager KJ; Savenka AV; Basnakian AG; Pathak R
Sci Rep; 2020 May; 10(1):7734. PubMed ID: 32382091
[TBL] [Abstract][Full Text] [Related]
13. ERK5/KLF2 activation is involved in the reducing effects of puerarin on monocyte adhesion to endothelial cells and atherosclerotic lesion in apolipoprotein E-deficient mice.
Deng Y; Lei T; Li H; Mo X; Wang Z; Ou H
Biochim Biophys Acta Mol Basis Dis; 2018 Aug; 1864(8):2590-2599. PubMed ID: 29723698
[TBL] [Abstract][Full Text] [Related]
14. Induction of endothelial dysfunction by oxidized low-density lipoproteins via downregulation of Erk-5/Mef2c/KLF2 signaling: Amelioration by fisetin.
Patel R; Varghese JF; Singh RP; Yadav UCS
Biochimie; 2019 Aug; 163():152-162. PubMed ID: 31199942
[TBL] [Abstract][Full Text] [Related]
15. Agonism of GPR120 prevents ox-LDL-induced attachment of monocytes to endothelial cells.
Jiang T; Jiang D; You D; Zhang L; Liu L; Zhao Q
Chem Biol Interact; 2020 Jan; 316():108916. PubMed ID: 31870843
[TBL] [Abstract][Full Text] [Related]
16. Antagonism of receptor interacting protein 1 using necrostatin-1 in oxidized LDL- induced endothelial injury.
An S; Qi Y; Zhang Z; Mo R; Hou L; Yao X; Ge J
Biomed Pharmacother; 2018 Dec; 108():1809-1815. PubMed ID: 30372886
[TBL] [Abstract][Full Text] [Related]
17. Klotho ameliorates oxidized low density lipoprotein (ox-LDL)-induced oxidative stress via regulating LOX-1 and PI3K/Akt/eNOS pathways.
Yao Y; Wang Y; Zhang Y; Liu C
Lipids Health Dis; 2017 Apr; 16(1):77. PubMed ID: 28407763
[TBL] [Abstract][Full Text] [Related]
18. Activation of GPR39 with the agonist TC-G 1008 ameliorates ox-LDL-induced attachment of monocytes to endothelial cells.
Xu Y; Wang M; Xie Y; Jiang Y; Liu M; Yu S; Wang B; Liu Q
Eur J Pharmacol; 2019 Sep; 858():172451. PubMed ID: 31202806
[TBL] [Abstract][Full Text] [Related]
19. The protective effects of aloperine against ox-LDL-induced endothelial dysfunction and inflammation in HUVECs.
Li W; Li Y; Zhao Y; Ren L
Artif Cells Nanomed Biotechnol; 2020 Dec; 48(1):107-115. PubMed ID: 31852304
[TBL] [Abstract][Full Text] [Related]
20. Histamine H1 type receptor antagonist loratadine ameliorates oxidized LDL induced endothelial dysfunction.
Zhou Y; Gao C; Wang H; Liu L; Huang Z; Fa X
Biomed Pharmacother; 2018 Oct; 106():1448-1453. PubMed ID: 30119218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
